Genetic Forms of Parkinson's Disease

Seminars in Neurology
Christine Y Kim, Roy N Alcalay

Abstract

One of the greatest advances in Parkinson's disease (PD) research in the past two decades has been a better understanding of PD genetics. Of the many candidate genes investigated, the best studied include LRRK2, SNCA, VPS35, Parkin, PINK1, and DJ1. The authors review the key clinical features of these monogenic forms, as well as for the prevalent risk factor gene, GBA, including the phenotype, clinical course, and treatment response. They also outline areas for future investigation: longitudinal studies of PD's clinical course, the identification of its premotor manifestations, and its specific mechanisms of pathogenicity.

Citations

Jun 27, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chiara FecchioPatrizia Polverino de Laureto
May 12, 2019·International Journal of Molecular Sciences·Carla Ribeiro Alvares BatistaAntonio Carlos Pinheiro de Oliveira
Nov 16, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Giovanni BellomoLucilla Parnetti
Feb 9, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Anwesha SanyalMatthew J LaVoie
Jun 15, 2018·International Journal of Molecular Medicine·Yunlu JiangBo Bai
Sep 12, 2019·NPJ Parkinson's Disease·Johanne LigaardLasse Pihlstrøm
Dec 13, 2019·Journal of Neural Transmission·András SalamonLászló Vécsei
Jan 31, 2020·Frontiers in Neurology·Alessandro GialluisiTeresa Esposito
Nov 5, 2019·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Roy N AlcalayMartha Nance
Dec 24, 2019·Journal of Parkinson's Disease·Ziv Gan-OrEdward A Fon
Mar 25, 2020·International Journal of Molecular Sciences·Wioletta Rozpędek-KamińskaIreneusz Majsterek
Nov 24, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Bingying DuLijun Hou
Dec 16, 2020·Journal of Genetic Counseling·Jennifer VerbruggeTatiana Foroud
Jul 19, 2020·La Revue de médecine interne·M AubignatP Krystkowiak
Nov 22, 2020·Neurology International·Amber EdinoffIvan Urits
Oct 27, 2020·Frontiers in Aging Neuroscience·Paulina Troncoso-EscuderoRene L Vidal
Feb 23, 2021·Frontiers in Neuroscience·Yanyan ZhangTian Tian
Mar 10, 2021·Current Neurology and Neuroscience Reports·Lola CookRoy N Alcalay
Mar 18, 2021·Scientific Reports·Martin WeberBaris Bingol
Oct 5, 2019·The Medical Clinics of North America·Katelyn PayneJoanne Wojcieszek
May 1, 2021·Stem Cell Research & Therapy·Elena Coccia, Tim Ahfeldt
Jun 5, 2021·Neurobiology of Aging·Anna HofmannUNKNOWN TREND Study Consortium
Jun 11, 2021·Frontiers in Neuroscience·Lorenzo GaetaniMassimiliano Di Filippo
Jun 10, 2021·Medicinal Research Reviews·Ramón CacabelosJuan C Carril
Jul 18, 2021·NPJ Parkinson's Disease·Daniel Macías-GarcíaPablo Mir
Aug 17, 2021·Cell Calcium·Dmitry LimAlexei Verkhratsky
Aug 15, 2021·Neurobiology of Disease·Abby L Olsen, Mel B Feany
May 11, 2021·Neurology. Clinical Practice·Lola CookTatiana Foroud

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Related Papers

Seminars in Neurology
Kishore R KumarAnne Grünewald
Expert Review of Neurotherapeutics
Michael R DouglasDavid J Nicholl
Molecular and Cellular Probes
C M Lill
© 2022 Meta ULC. All rights reserved